Frank L. Douglas '66 is an award-winning and longtime veteran in the field of healthcare and pharmaceuticals. Douglas is Chief Executive Officer of Florida-based TheVax Genetics Vaccine Company. He is also a member of the board at TheVax and is co-founder of Douglas Ahmed Consulting (DAC).
As CEO of TheVax Genetics Vaccine Company, Douglas leads a company that uses immunotherapy to address virus induced tumors and infections in patients in an effort to improve the quality of life and longevity of its patients.
Prior to joining TheVax, Douglas served as President and CEO of the Austen BioInnovation Institute in Akron; Executive Vice President, Chief Scientific Officer and Member of the Board of Management of Aventis AG; Chief Scientific Advisor of Bayer Healthcare, AG; Founder and First Executive Director of the MIT Center for Biomedical Innovation; Professor of Practice at Massachusetts Institute of Technology's (MIT) Sloan School of Management, MIT Departments of Chemistry, Biomedical Engineering and the Harvard-MIT Division of Health Science and Technology.
Douglas has been the recipient of several honors, including the Weill Cornell Medical College Alumni Special Achievement Award (2016), Ewing Marion Kauffman Foundation Medal for Distinguished Service (2013), Geoffrey Beene Foundation and GQ Magazine Rock Star of Science Award (2010), Black History Makers Award (2007), Medal of Honor at Johann Wolfgang von Goethe University of Frankfurt (2004), Global Pharmaceutical R&D Director of the Year Award (2004 & 2001), National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChe) Lifetime Achievement Award (2002), Louis B. Russell Memorial American Heart Association Award (1986) and Chicago Heart Association's Heart of the Year Award (1985).
He is a Fellow of the High Blood Pressure Council. He is a former member of the Board of Trustees at Lehigh University and the Wolfgang von Goeth University of Frankfurt, Germany. Douglas also serves on the board of directors of Gene Logic, Inc., Nitromed, Inc., and is chairman of the board of directors of Alantos Pharmaceuticals, Inc.
Douglas earned a Bachelor of Science degree in engineering, cum laude, from Lehigh in 1966. He earned his Ph.D. in Physical Chemistry and M.D. from Cornell University and completed his internship and residency in internal medicine at the Johns Hopkins Medical Institution and a fellowship in neuroendocrinology at the National Institutes of Health.